跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Co-Ivyzar - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Co-Ivyzar
Approved
STANDARD
Co-Ivyzar
Interphil Laboratories
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
465434b770e8676b
Company
Interphil Laboratories
Type
Standard
Approval Details
Approval Id
465434b770e8676b
Drug Approval Philippines Name
Co-Ivyzar
Product Name
Co-Ivyzar
Registration Number
DRP-4372
Brand Name
Co-Ivyzar
Generic Name
Irbesartan + Hydrochlorothiazide
Dosage Form
Tablet
Dosage Strength
300 mg/ 12.5 mg
Manufacturer
Interphil Laboratories
Issuance Date
28 January 2022
Expiry Date
17 February 2027
Pharmacologic Category
Angiotensin Receptor Blocker/ Diuretic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
465434b770e8676b
Type
Standard
Back to Philippines FDA Approvals